文献速递帕金森病与运动障碍认知障碍与痴呆

帕金森病合并阻塞性睡眠呼吸暂停患者的认知功能下降

Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
PubMed 文献 · Neurology · 2017-02-22

该研究纳入67例特发性帕金森病患者,通过整夜多导睡眠图评估阻塞性睡眠呼吸暂停(OSA,定义为呼吸暂停低通气指数AHI≥15/h)与非运动症状的关联。结果显示OSA与日间嗜睡和认知功能障碍相关,提示OSA可能是帕金森病非运动症状的可逆性 contributing factor。

要点

  • 帕金森病患者中OSA患病率高,且与认知功能下降相关。
  • OSA严重程度与日间嗜睡和认知功能评分独立相关。
  • 治疗OSA或可改善帕金森病患者的嗜睡和认知功能。

核心结论

  • OSA与帕金森病患者的日间嗜睡和认知功能障碍相关,提示OSA可能是这些非运动症状的可逆性因素。

研究设计与样本

  • 研究纳入67例来自运动障碍门诊的特发性帕金森病患者,进行整夜多导睡眠图检查,OSA定义为AHI≥15/h。

主要发现

  • 67例患者中OSA占61.6%(47例),平均AHI为27.1/h(SD 20.2/h),非运动症状占85%(57例)。
  • Epworth嗜睡量表(ESS)评分与AHI(β=0.0670,p=0.031)、呼吸相关觉醒(β=0.1015,p=0.011)和间歇性低氧(β=0.1470,p=0.006)相关。
  • 蒙特利尔认知评估(MoCA)评分与AHI(β=-0.0520,p=0.043)和呼吸相关觉醒(β=-0.0596,p=0.049)负相关,但与间歇性低氧无显著相关。

关键数值与推荐

  • OSA定义为呼吸暂停低通气指数(AHI)≥15/h。
  • 认知功能评估采用蒙特利尔认知评估(MoCA),嗜睡评估采用Epworth嗜睡量表(ESS)。

临床怎么用

  • 对帕金森病患者应筛查OSA,尤其是存在日间嗜睡或认知功能障碍者。
  • OSA可能是帕金森病非运动症状的可治疗因素,需进一步研究治疗OSA能否改善嗜睡和认知。

局限性

  • 本研究为横断面设计,无法确定因果关系。
  • 样本量较小(67例),需更大样本验证。
  • 未评估OSA治疗对非运动症状的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the association between obstructive sleep apnea (OSA) and nonmotor symptoms (NMS), including cognitive dysfunction, in patients with Parkinson disease (PD). METHODS: Patients with idiopathic PD, recruited from a movement disorder clinic, underwent overnight polysomnography. OSA was defined as an apnea-hypopnea index (AHI) ≥15/h. PD severity was assessed using the Hoehn & Yahr (H&Y) scale and the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). NMS were assessed using the Montreal Cognitive Assessment (MoCA), Epworth Sleepiness Scale (ESS), Fatigue Severity Scale, Apathy Scale, Beck Depression Inventory, Hospital Depression and Anxiety Scale, and PD sleep Scale. RESULTS: Sixty-seven patients (61.2% male), mean age 64.4 (SD 9.9) years and motor MDS-UPDRS 21.9 (12.6) using levodopa equivalent dose (LED) 752.4 (714.6) mg/d, were studied. OSA occurred in 47 patients (61.6%, mean AHI 27.1/h, SD 20.2/h), and NMS in 57 patients (85%). ESS and MoCA were associated with the AHI (ESS β = 0.0670, p = 0.031; MoCA β = -0.0520, p = 0.043, adjusted for age, sex, body mass index, LED, and H&Y). ESS was associated with respiratory arousals (β = 0.1015, p = 0.011) and intermittent hypoxemia (β = 0.1470, p = 0.006). MoCA was negatively associated with respiratory arousals (β = -0.0596, p = 0.049) but not intermittent hypoxemia. CONCLUSIONS: OSA is associated with sleepiness and cognitive dysfunction in PD, suggesting that OSA may be a reversible contributor to these NMS. Further studies will be required to evaluate whether OSA treatment can improve excessive sleepiness and cognitive dysfunction in PD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mery VP, Gros P, Lafontaine AL, et al. Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea. Neurology. 2017. PMID: 28228566. doi:10.1212/WNL.0000000000003738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。